Arthur-Quan Tran, MD

Opinion

PARP inhibitors: New developments in ovarian cancer treatment

Author:

Arthur-Quan Tran, MD

Maturing data from ongoing trials will likely expand the opportunity to use PARP inhibitors for the treatment of ovarian cancer.

• Read More